Iguratimod - Toyama Chemical

Drug Profile

Iguratimod - Toyama Chemical

Alternative Names: Careram; Kolbet; T-614

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Toyama Chemical
  • Developer Eisai Co Ltd; Toyama Chemical
  • Class Analgesics; Anti-inflammatories; Antipyretics; Antirheumatics; Benzopyrans; Chromones; Small molecules; Sulfonamides
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors; Cytokine inhibitors; Tumour necrosis factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Rheumatoid arthritis

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 01 Dec 2015 The Japanese Ministry of Health, Labour and Welfare lifts the All-case surveillance condition required for approval of iguratimod for Rheumatoid arthritis in Japan
  • 01 Dec 2015 Interim adverse events and efficacy data from a post-marketing study in Rheumatoid arthritis released by Eisai and Toyama Chemical
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top